NO941581D0 - - Google Patents

Info

Publication number
NO941581D0
NO941581D0 NO941581A NO941581A NO941581D0 NO 941581 D0 NO941581 D0 NO 941581D0 NO 941581 A NO941581 A NO 941581A NO 941581 A NO941581 A NO 941581A NO 941581 D0 NO941581 D0 NO 941581D0
Authority
NO
Norway
Prior art keywords
glucan
yeast
yeast cell
glucanese
solubilization
Prior art date
Application number
NO941581A
Other languages
English (en)
Norwegian (no)
Other versions
NO300692B1 (no
NO941581L (no
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19897060&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO941581(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to NO941581A priority Critical patent/NO300692B1/no
Publication of NO941581D0 publication Critical patent/NO941581D0/no
Priority to DE69527955T priority patent/DE69527955T2/de
Priority to DK95914485T priority patent/DK0759089T3/da
Priority to AU21464/95A priority patent/AU703251B2/en
Priority to JP52809395A priority patent/JP3992730B2/ja
Priority to CA2189010A priority patent/CA2189010C/en
Priority to ES95914485T priority patent/ES2182898T3/es
Priority to EP95914485A priority patent/EP0759089B1/de
Priority to PCT/IB1995/000265 priority patent/WO1995030022A1/en
Priority to AT95914485T priority patent/ATE222958T1/de
Publication of NO941581L publication Critical patent/NO941581L/no
Priority to FI964339A priority patent/FI114807B/fi
Publication of NO300692B1 publication Critical patent/NO300692B1/no
Priority to US11/093,427 priority patent/US7883875B2/en
Priority to JP2007130872A priority patent/JP2007228974A/ja
Priority to US11/951,811 priority patent/US8142785B2/en
Priority to JP2008290653A priority patent/JP2009051863A/ja
Priority to US12/978,923 priority patent/US8252295B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/42—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds characterised by the carbohydrates used, e.g. polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Materials Engineering (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO941581A 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan NO300692B1 (no)

Priority Applications (16)

Application Number Priority Date Filing Date Title
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
PCT/IB1995/000265 WO1995030022A1 (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans
DK95914485T DK0759089T3 (da) 1994-04-29 1995-04-18 Behandling af glucaner med enzymer
EP95914485A EP0759089B1 (de) 1994-04-29 1995-04-18 Behandlung von glucanen mit enzymen
AT95914485T ATE222958T1 (de) 1994-04-29 1995-04-18 Behandlung von glucanen mit enzymen
AU21464/95A AU703251B2 (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans
JP52809395A JP3992730B2 (ja) 1994-04-29 1995-04-18 グルカンの酵素処理
CA2189010A CA2189010C (en) 1994-04-29 1995-04-18 Enzyme treatment of glucans
ES95914485T ES2182898T3 (es) 1994-04-29 1995-04-18 Tratamiento enzimatico de glucanos.
DE69527955T DE69527955T2 (de) 1994-04-29 1995-04-18 Behandlung von glucanen mit enzymen
FI964339A FI114807B (fi) 1994-04-29 1996-10-28 Glukaanien entsyymikäsittely
US11/093,427 US7883875B2 (en) 1994-04-29 2005-03-30 Method or use of a solubilized glucan product to increase immunostimulation in animals
JP2007130872A JP2007228974A (ja) 1994-04-29 2007-05-16 グルカンの酵素処理
US11/951,811 US8142785B2 (en) 1994-04-29 2007-12-06 Method or use of a solubilized glucan product to increase immunostimulation in animals
JP2008290653A JP2009051863A (ja) 1994-04-29 2008-11-13 免疫刺激組成物を製造するためのグルカンの使用及び薬剤としてのグルカンの使用
US12/978,923 US8252295B2 (en) 1994-04-29 2010-12-27 Enzyme treatment of glucans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Publications (3)

Publication Number Publication Date
NO941581D0 true NO941581D0 (de) 1994-04-29
NO941581L NO941581L (no) 1995-10-30
NO300692B1 NO300692B1 (no) 1997-07-07

Family

ID=19897060

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941581A NO300692B1 (no) 1994-04-29 1994-04-29 Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Country Status (12)

Country Link
US (3) US7883875B2 (de)
EP (1) EP0759089B1 (de)
JP (3) JP3992730B2 (de)
AT (1) ATE222958T1 (de)
AU (1) AU703251B2 (de)
CA (1) CA2189010C (de)
DE (1) DE69527955T2 (de)
DK (1) DK0759089T3 (de)
ES (1) ES2182898T3 (de)
FI (1) FI114807B (de)
NO (1) NO300692B1 (de)
WO (1) WO1995030022A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO300692B1 (no) * 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
DE19911052A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Sonnenschutzmittel
DE19911055A1 (de) * 1999-03-12 2000-09-21 Cognis Deutschland Gmbh Verwendung von oberflächenaktiven Gemischen
DE19911057C2 (de) * 1999-03-12 2001-01-25 Cognis Deutschland Gmbh Haarkosmetische Zubereitungen
DE19911058B4 (de) * 1999-03-12 2004-09-30 Biotec Asa Verwendung von nanoskaligen wasserlöslichen β-(1,3)-Glucanen
DE19911056B9 (de) * 1999-03-12 2005-09-08 Biotec Asa Kosmetische Zubereitungen und deren Verwendung
US8912165B2 (en) 1999-03-12 2014-12-16 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
US8501710B2 (en) * 1999-03-12 2013-08-06 Biotec Pharmacon Asa Methods of skin treatment and use of water-soluble β-(1,3) glucans as active agents for producing therapeutic skin treatment agents
WO2000054742A1 (de) * 1999-03-12 2000-09-21 Biotec Asa VERWENDUNG VON WASSERLÖSLICHEN β-(1,3)-GLUCANEN ALS WIRKSTOFFE ZUR HERSTELLUNG VON THERAPEUTISCHEN MITTELN ZUR HAUTBEHANDLUNG
DE19911053B4 (de) 1999-03-12 2004-10-28 Biotec Asa Kosmetische und/oder pharmazeutische Zubereitungen
DE19917744A1 (de) * 1999-04-20 2000-10-26 Cognis Deutschland Gmbh Dekorative kosmetische Zubereitungen
DE19917743C2 (de) * 1999-04-20 2003-08-14 Biotec Asa Desodorierende Zubereitungen
DE19920557B4 (de) * 1999-05-05 2004-09-09 Biotec Asa Verfahren zur Herstellung von Kollagenfreien kosmetischen Zubereitungen
US20020009463A1 (en) * 2000-02-23 2002-01-24 Jan Raa Novel, non-antigenic, mucosal adjuvant formulation which enhances the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
US7507724B2 (en) 2001-01-16 2009-03-24 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
US7906492B2 (en) 2001-01-16 2011-03-15 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
BE1014638A6 (fr) * 2002-02-12 2004-02-03 Univ Liege Methode de preparation de derives de la paroi cellulaire a partir de biomasse.
GB0211118D0 (en) 2002-05-15 2002-06-26 Polonelli Luciano Vaccines
US7018986B2 (en) * 2002-09-20 2006-03-28 Immudyne Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption
US20050180964A1 (en) 2003-03-17 2005-08-18 Puntenney Steven B. Methods and compositions for the inhibition of growth of infectious Aspergillus fumigatus and other mycotic organisms in the gut of mammalian and avian species
JP2004210895A (ja) * 2002-12-27 2004-07-29 Immudyne Japan:Kk 免疫機能を有する可能性β−グルカンの製造方法及び用途
ATE426037T1 (de) 2004-02-13 2009-04-15 Alpron Co Ltd Verfahren zur herstellung von aus hefe stammendem glucan
US20050220846A1 (en) 2004-04-05 2005-10-06 Puntenney Steven B Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4) glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
AU2004218698B2 (en) * 2004-10-08 2011-06-09 Biotec BetaGlucans AS Method
JP4570949B2 (ja) * 2004-12-13 2010-10-27 株式会社アルプロン 酵母由来グルカンの製造方法
WO2007021262A1 (en) * 2005-08-10 2007-02-22 Steven Bruce Puntenney USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION
US8323644B2 (en) 2006-01-17 2012-12-04 Sloan-Kettering Institute For Cancer Research Therapy-enhancing glucan
JP2009528267A (ja) * 2006-01-17 2009-08-06 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ 治療を増強するグルカン
US8142798B2 (en) 2006-04-26 2012-03-27 OmniGen Research, L.L.C. Augmentation of titer for vaccination in animals
US9457047B2 (en) 2006-11-06 2016-10-04 Whitehead Institute Immunomodulating compositions and methods of use thereof
ES2397186T3 (es) * 2006-11-06 2013-03-05 Whitehead Institute Composiciones inmunomoduladoras y métodos para su uso
US20100322923A1 (en) * 2007-02-21 2010-12-23 Biotec Pharmacon Asa Medical Uses of Glucans
MX2009012070A (es) * 2007-05-08 2009-12-08 Biopolymer Engineering Inc Dba Preparacion de glucano soluble en particulas.
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
EP2211900A1 (de) * 2007-11-19 2010-08-04 Calanus AS Bioaktive ruderfusskrebs-zusammensetzungen, verfahren zu ihrer herstellung und ihre verwendung zur verhinderung oder behandlung der infektion von wirten durch phylogenetisch ähnliche ektoparasiten
ES2599908T3 (es) 2007-11-26 2017-02-06 Glaxosmithkline Biologicals Sa Glucanos beta-1,3-enlazados conjugados
BRPI0900639C1 (pt) * 2009-02-13 2011-12-20 Hebron Farmaceutica Pesquisa Desenvolvimento E Inovacao Tecnologica Ltda composição farmacêutica e uso desta para tratamento e/ou prevenção de doenças do trato respiratório
ES2873502T3 (es) 2009-03-27 2021-11-03 Bend Res Inc Proceso de secado por pulverización
JP5242855B2 (ja) * 2010-07-29 2013-07-24 国立大学法人北海道大学 免疫アジュバント
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
PT2611529T (pt) 2010-09-03 2019-05-09 Bend Res Inc Método de secagem por pulverização
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
GB201020190D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
GB201020191D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
GB201020193D0 (en) 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan compositions
EP2694030A2 (de) 2011-03-04 2014-02-12 Sana Pharma AS Kosmetische formulierungen
FR2981075A1 (fr) 2011-10-11 2013-04-12 Kitozyme Procede de preparation de glucans a partir d'aspergillus niger
MD4329C1 (ro) * 2013-10-30 2015-09-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Procedeu de cultivare a tulpinii de levuri Saccharomyces cerevisiae CNMN-Y-20
EP3110437B1 (de) 2014-02-12 2017-11-29 Omnigen Research, LLC Zusammensetzung und verfahren zur förderung der reduktion von hitzestress bei tieren
EP3212169B1 (de) 2014-10-31 2021-01-13 Bend Research, Inc. Verfahren zur herstellung von in einer matrix dispergierten aktiven domänen
CA2997553A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A particulate composition comprising silica, mineral clay, glucan and mannans for aquaculture

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2764463A (en) 1953-05-26 1956-09-25 Underwood Corp Magnetic recording system
US3954979A (en) * 1972-11-24 1976-05-04 Ceres Products Company, Inc. Process for preparing stabilized yeast and compositions and tableting composition and method
JPS5432076B2 (de) 1973-09-14 1979-10-11
JPS54138115A (en) * 1978-04-17 1979-10-26 Kirin Brewery Antiicancer agent
GB2076418A (en) 1980-05-22 1981-12-02 Sankyo Co Hydrolyzed polysaccharide
JPS6019619B2 (ja) 1980-09-19 1985-05-17 株式会社日立製作所 Ｘ線管用回転陽極
SE456911B (sv) 1983-12-19 1988-11-14 Olle Larm Vattenloeslig, aminerad beta-1,3-bunden d-glukan och makrofagstimulerande komposition innehaallande densamma
JPS60196195A (ja) 1984-03-21 1985-10-04 Dainippon Seito Kk イ−ストグルカンの製造法
US4992540A (en) 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US4810646A (en) 1984-11-28 1989-03-07 Massachusetts Institute Of Technology Glucan compositions and process for preparation thereof
US5028703A (en) * 1988-03-11 1991-07-02 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5082936A (en) 1984-11-28 1992-01-21 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
US5057503A (en) * 1989-01-23 1991-10-15 The Brigham And Women's Hospital Derivativized polysaccharides with biologic activity, method of their isolation, and uses therefor
CA1330303C (en) 1989-02-20 1994-06-21 Libor Henry Nikl Composition and process to enhance the efficacy of a fish vaccine
JPH05503952A (ja) * 1989-09-08 1993-06-24 アルファ　ベータ　テクノロジー，インコーポレイティッド 可溶性グルカン類の製造方法
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
WO1991003248A2 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for immune system activation
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
US6020324A (en) * 1989-10-20 2000-02-01 The Collaborative Group, Ltd. Glucan dietary additives
CA2040374C (en) * 1990-07-06 1998-06-16 Gunnar Rorstad Process for enhancing the resistance of aquatic animals to disease
NO300692B1 (no) 1994-04-29 1997-07-07 Biotec Mackzymal As Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan

Also Published As

Publication number Publication date
ES2182898T3 (es) 2003-03-16
WO1995030022A1 (en) 1995-11-09
ATE222958T1 (de) 2002-09-15
US20110104208A1 (en) 2011-05-05
US8142785B2 (en) 2012-03-27
FI964339A (fi) 1996-10-28
AU703251B2 (en) 1999-03-25
US20080124349A1 (en) 2008-05-29
JP2007228974A (ja) 2007-09-13
DK0759089T3 (da) 2003-01-06
US7883875B2 (en) 2011-02-08
US20050255565A1 (en) 2005-11-17
NO300692B1 (no) 1997-07-07
FI964339A0 (fi) 1996-10-28
CA2189010A1 (en) 1995-11-09
CA2189010C (en) 2010-07-13
US8252295B2 (en) 2012-08-28
EP0759089B1 (de) 2002-08-28
AU2146495A (en) 1995-11-29
FI114807B (fi) 2004-12-31
DE69527955D1 (de) 2002-10-02
NO941581L (no) 1995-10-30
JP3992730B2 (ja) 2007-10-17
JP2009051863A (ja) 2009-03-12
DE69527955T2 (de) 2003-04-10
JPH09512708A (ja) 1997-12-22
EP0759089A1 (de) 1997-02-26

Similar Documents

Publication Publication Date Title
NO941581D0 (de)
AU6229686A (en) Soluble phosphorylated glucan
AU8596791A (en) Yeast
GB9022560D0 (en) Processing of waste
CA2013190A1 (en) Method of producing stable bran and flour products from cereal grains
CA2083481A1 (en) Feed composition for mother sows
EP0249629A4 (de) Verfahren und mittel zur erleichterung der schmerzen maligner tumore.
DE69431162D1 (en) Fenbendazolformulierungen
AU5501396A (en) Small particle size p-type zeolite
IE871529L (en) Biologic response modifier
AU7573300A (en) Liberating intracellular matter from biological material
SI1196182T1 (sl) Postopek za povečanje zmogljivosti proizvodnje pri živali
AU3306984A (en) L-aminoacid oxidase from yeasts of the genus cryptococcus, their preparation and use
MY124118A (en) Organometallic-metabolizing yeast
HK1005360A1 (en) Germanium yeast human diet nutritional supplement
钮学新 et al. Dynamic-statistic method for forecasting the intensity of tropical cyclone
IE800772L (en) Immunostimulant substance
EP1237093A3 (de) Verfahren und System zur Zuordnung von Zeichen-Codes zu optimierten Zeichen-Codes
SU663722A1 (ru) Штамп дрожжей в-41 дл хересовани виноматериалов
UA11935A1 (uk) Гібридhий штам дріжджів sассhаrомyсеs сеrеvіsіае, який використовується для одержання хлібопекарських дріжджів
CA2087621A1 (en) Livestock Feed from Potato Waste
杉森尚美 Administration of G-CSF to normal individuals diminishes L-selectin [+] T cells in the peripheral blood that respond better to alloantigen stimulation than L-selectin [-] T cells
Voiculescu Experimental study on enterobacterial LPS as inducer of IL-1 monokine in mouse tumor surveillance.
Rusinov Linear selection of highly productive strains of Penicillium chrysogenum
MY134838A (en) Germanium yeast human diet nutritional supplement

Legal Events

Date Code Title Description
MK1K Patent expired